Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Colgate Primed For Natural “Wave,” Touts Mexican, Russian Markets

This article was originally published in The Tan Sheet

Executive Summary

Colgate-Palmolive expects to be positioned to ride what President and COO Ian Cook calls a "wave" of growth in natural oral care products through its majority-owned subsidiary Tom's of Maine

You may also be interested in...



Colgate Q3 Sales Increase, But Profits Decline With Charges, Restructuring

Increased spending on advertising helped Colgate-Palmolive remain the leader in the U.S. toothpaste market during the third quarter, according to an Oct. 25 announcement of the firm's earnings during the period

Colgate President Cook Slated For CEO Post After Mark’s 2007 Retirement

Colgate-Palmolive President and COO Ian Cook will take over the chief executive position after current Chairman and CEO Reuben Mark retires in 2007, according to Mark

Abbott's ‘Bedrock Of Good Health’ Nutritionals Business Faces Mounting Infant Formula Litigation

Nutritional product business had 5.1% Q1 sales growth and is like Abbott’s other segments, “super well-aligned to the global demographics and trends in health care,” says CEO Ford. But as it defends complaints of damages from powder formulas made at facility found with unsafe levels of bacterial contaminants, Abbott’s also targeted in litigation alleging failure to warn about risk of infants born prematurely developing necrotizing enterocolitis if fed cow’s milk-based formula.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS099957

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel